by Staff Writer
Innovation Depot News
Birmingham-based Soluble Therapeutics Inc. has won a $1 million grant from the National Institutes of Health which will be used in the creation of a machine to help pharmaceutical companies in the drug development process.
According to the Birmingham News, the biotechnology company, which is based at Innovation Depot, won the NIH grant as part of the Small Business Technology Transfer Program.
The money will go toward accelerating Soluble Therapeutics’ commercialization of a technology that pharmaceutical companies can use in identifying formulations for protein-based drugs, often injectable drugs such as for cancers and auto-immune disorders.
To read the Innovation Depot news article, click here.